Bliss GVS Pharma share news, announcements and annual reports
NSE: BLISSGVSBSE: 506197Pharmaceuticals & BiotechnologySmall Cap
Bliss GVS Pharma Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1985 on BSE, Jul 2010 on NSE
Last close ₹680.90up ₹32.40 (5.00%)BSE ₹682.50
Share price at the NSE close on 29 Oct 2026. Previous close ₹648.50.
29 Oct: open ₹667.95, high ₹680.90, low ₹652.75
52-week range of traded prices to 29 Oct 2026
₹118.00Low, 10 Nov 2025₹739.90High, 28 Sep 2026
- Under NSE's long-term additional surveillance, stage IV, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,240 Cr1,000th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 44.92
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.61
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.22%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 4,47,694
Bliss GVS Pharma board and management
31 filed, newest first.
Sep 2026
29 Sep · Management
Jul 2026
24 Jul · Management
24 Jul · Management
3 Jul · Management
Apr 2026
Feb 2026
Nov 2025
May 2025
12 May · Management
Mar 2025
27 Mar · Management
Jan 2025
16 Jan · Management
Jun 2024
Dec 2022
Jun 2022
Jul 2021
May 2021
11 May · Management
Jun 2020
Feb 2020
Feb 2018
Jan 2018
Mar 2014
19 Mar · Management
Mrs. Sushma Yadav is appointed as a Company Secretary of the Company on account of resignation of Mr. Amarendra Mohapatra.
Aug 2012
8 Aug · Management
Ms. Jyoti Asawa Company Secretary resign from the Company with immediate effect.
Jun 2011
9 Jun · Management
Board of Directors of the Company at its meeting held on May 30, 2011 has approved: (1) Appointment of Mr. Mayak Mehta as Independent Director of the Company.
Apr 2011
25 Apr · Management
Mr. Yogendra N. Thakkar is tended his resignation as an Independent Director of the Company on April 21, 2011 due to his personal reasons.
Mar 2011
22 Mar · Management
Mr. Satej M. Katekar is tended his resignation as an Independent Director of the Company on March 21, 2011 due to pre occupation.
Jul 2010
30 Jul · Management
Board of Directors of the Company at its meeting held on July 28, 2010 has approved: (1) Subject to section 314 of the Companies Act 1956 Mr.Gagan Harsh Sharma appointed as General Manager of the Company relative of Mr. S.N. Kamath-Promoter & Managing Director of the Company.